NCT04691037 CCTA Improves Clinical Management of Stable Chest Pain
| NCT ID | NCT04691037 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tianjin Chest Hospital |
| Condition | Coronary Computed Tomography Angiography |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2016-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2016-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigator aims to prospectively enroll patients who were referred for coronary computed tomography angiography (CCTA) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary. This study will determine if CCTA-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
Eligibility Criteria
Inclusion Criteria: * symptomatic patients with SCP suspected of obstructive CAD. * referred for CCTA for the assessment of SCP. * ≥18 years of age. * signed informed consent. Exclusion Criteria: * acute coronary syndromes * previous CAD or coronary revascularization * nonsinus rhythm * cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04691037 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Coronary Computed Tomography Angiography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04691037 currently recruiting?
Yes, NCT04691037 is actively recruiting participants. Contact the research team at zhoujiawenzhang@126.com for enrollment information.
Where is the NCT04691037 trial being conducted?
This trial is being conducted at Beijing, China, Langfang, China, Tianjin, China, Tianjin, China.
Who is sponsoring the NCT04691037 clinical trial?
NCT04691037 is sponsored by Tianjin Chest Hospital. The trial plans to enroll 50,000 participants.